Hypothesis

Morning exposure to blue‑enriched light (≈10,000 lux, 30 min within the first hour of waking) preconditiones retinal melanopsin signaling to boost a circadian‑dependent antioxidant program that synergizes with nocturnal melatonin to inhibit the TRPV1‑YAP pathway, thereby reducing oxidative DNA damage and senescence markers.

Mechanistic Rationale

1. Melanopsin‑driven sympathetic surge – Morning blue light activates ipRGCs, increasing sympathetic output and hepatic β‑adrenergic signaling. This elevates cAMP‑PKC activity, leading to phosphorylation and activation of the NAD⁺ salvage enzyme NAMPT, raising intracellular NAD⁺ levels.
2. NAD⁺‑SIRT1 axis – Higher NAD⁺ fuels SIRT1 deacetylase activity. SIRT1 deacetylates YAP at Lys‑494, promoting its cytoplasmic retention and inhibiting its nuclear transcriptional program that upregulates TRPV1 expression.
3. Melatonin amplification – The same morning light pulse advances the phase of the suprachiasmatic nucleus, producing a larger nocturnal melatonin surge (6‑7‑fold as shown in [3]). Melatonin, acting through MT1/MT2 receptors, further suppresses TRPV1 channel activity and scavenges residual ROS.
4. Combined effect on TRPV1‑YAP – With YAP kept inactive and TRPV1 less active, the feed‑forward loop that converts blue‑light‑induced ROS into YAP‑driven pro‑oxidant transcription is broken. Consequently, keratinocytes (and other light‑exposed tissues) experience lower 8‑OHdG formation and reduced SASP secretion.

Testable Predictions

• Prediction 1: In healthy volunteers, a 4‑week regimen of mo

Hypothesis

The global, non‑selective loss of H3K27me3 observed in aged neurons stems from constitutive low catalytic activity of KDM6A/B demethylases driven by a declining α‑ketoglutarate/succinate ratio, whereas in cancer cells oncogenic signaling pathways (e.g., mTORC1‑4E‑BP‑EZH2 axis) locally phosphorylate and activate KDM6A/B, producing focused H3K27me3 removal at bivalent promoters of metastasis‑related genes.

Mechanistic basis

1. Co‑factor dependence – KDM6A/B are Fe(II)/α‑KG‑dependent dioxygenases; their activity falls when intracellular succinate accumulates or α‑KG declines. Aging neurons exhibit mitochondrial dysfunction and elevated succinate, predicting a basal reduction in demethylase velocity across the genome.
2. Signal‑dependent phosphorylation – Recent work shows mTORC1 enhances EZH2 translation via 4E‑BP, but mTORC1 also sustains S6K1‑mediated phosphorylation of KDM6B at Ser^xxx (hypothetical site). This modification increases KDM6B’s Vmax without altering protein levels, creating a permissive state for rapid demethylation only where mTORC1 is hyperactive, such as at oncogene promoters.
3. Chromatin accessibility feedback – H3K27me3 loss facilitates binding of pioneer factors (e.g., FOXM1) that further recruit mTORC1 complexes, reinforcing a local loop that sharpens the demethylation signal in cancer but is absent in aged tissue where chromatin remains relatively closed.

Testable predictions

• Prediction 1: Nuclear extracts from middle‑aged mouse neurons will show ~30‑40 % lower KDM6A/B demethylase activity (measured by succina

Hypothesis

Engineered iPSC lines lacking HLA class I/II and expressing PD‑L1 generate cardiomyocytes that engraft in aged myocardial tissue, survive long term, and improve function without requiring chronic immunosuppression.

Mechanistic Rationale

Aged hearts exhibit heightened innate immune surveillance and reduced regenerative capacity, which contributes to poor outcomes after cell therapyiPSC dominance. HLA molecules on graft cells trigger recipient T‑cell activation, while PD‑L1 engagement delivers inhibitory signals that dampen effector responses. Removing HLA eliminates direct antigen presentation, and overexpressing PD‑L1 reinforces peripheral tolerance. In aged tissue, senescent cells secrete SASP factors that can upregulate PD‑1 on infiltrating lymphocytes, making PD‑L1 blockade a relevant checkpointiPSC immunoevasion. Combining HLA knockout with PD‑L1 overexpression should therefore create a double shield: loss of antigenic visibility plus active inhibition of residual immune activity.

Testable Predictions

1. iPSC‑derived cardiomyocytes with HLA‑KO/PD‑L1 will show <5 % T‑cell mediated lysis in vitro compared with wild‑type iPSC‑cardiomyocytes when co‑cultured with aged human peripheral blood mononuclear cells.
2. In immunodeficient mice reconstituted with aged human immune cells, grafts of HLA‑KO/PD‑L1 cardiomyocytes will retain >70 % engraftment at 8 weeks, whereas wild‑type grafts will dr

Hypothesis

Age‑associated mtDNA mutations deplete ATP in colonic enterocytes, compromising ATP‑dependent chaperones and the VCP/p97 segregase that extracts misfolded tight‑junction proteins for proteasomal degradation. When ATP falls, VCP activity stalls, leading to accumulation of ubiquitinated ZO‑1 and occludin that are shunted to lysosomal autophagy, ultimately degrading junctional complexes despite unchanged gene expression. This energetic proteostasis failure explains the protein‑gene discordance observed in aging gut barriers and provides a direct mechanistic bridge from mtDNA damage to barrier leak and local inflammaging.

Mechanistic Rationale

1. ATP shortage – OXPHOS deficiency from mtDNA lesions reduces cytosolic ATP below the threshold needed for VCP/p97 ATPase cycles (4).
2. VCP/p97 dependence – VCP extracts ubiquitinated junctional proteins from complexes; its inhibition causes ZO‑1/occludin accumulation and subsequent autophagic clearance (5).
3. Proteostasis shift – Low ATP favors autophagy over proteasome, diverting ubiquitinated junctional proteins to lysosomes where they are degraded.
4. Barrier outcome – Loss of ZO‑1/occludin weakens paracellular sealing, increasing permeability and enabling microbial product translocation that fuels IFN‑γ, IL‑6, IL‑1β production (2).

Testable Predictions

• Prediction 1: In aged mice or PolG mutator enterocytes, ATP levels will correlate posi

OSK selects for low-heteroplasmy mitochondria

Hypothesis: OSK-induced partial reprogramming drives epigenetic age reversal by eliminating cells harboring high mtDNA heteroplasmy, thereby linking mitochondrial genome quality to methylation clock read‑outs.

Mechanistic rationale

• OSK triggers a transient pluripotent state that activates mitophagy and mitochondrial biogenesis pathways [3].
• Cells with high heteroplasmy produce excess ROS and reduced ATP, activating stress‑sensitive kinases (e.g., AMPK, p38 MAPK) that favor apoptosis or differentiation rather than reprogramming [4].
• Consequently, the surviving iPSC‑like population becomes enriched for mitochondria with low mutation load, shifting the bulk heteroplasmy distribution downward [2].
• Reduced heteroplasmy normalizes TCA‑cycle metabolites (acetyl‑CoA, α‑ketoglutarate) that serve as cofactors for TET enzymes and HDACs, allowing the methylation clock to reset [1].

Testable predictions

1. In OSK-treated aged mice, single‑cell mtDNA heteroplasmy will show a bimodal shift: a loss of cells >60% heteroplasmy and a gain of cells <20% heteroplasmy, correlating with regional epigenetic age reduction measured by bisulfite sequencing.
2. Pharmacological inhibition of mitophagy (e.g., with Mdivi‑1) during OSK expression will block heteroplasmy clearing and attenuate epigenetic age reversal, despite normal OSK transduction.
3. Forced expression of a ROS‑scavenging enzyme (mito‑CAT) in high‑heteroplasmy fibroblasts will rescue their reprogramming efficiency to levels seen in low‑heteroplasmy cells, indicating

Hypothesis

The Wolverine stack (BPC-157 + TB-500) reduces pathological fibrosis more effectively than either peptide alone by concurrently suppressing TGF‑β/Smad signaling and limiting nuclear actin‑dependent transcriptional coactivators that drive myofibroblast differentiation.

Mechanistic Rationale

• BPC-157 upregulates VEGF and nitric oxide (NO) pathways, increasing cGMP‑PKG activity. PKG phosphorylates the linker region of Smad2/3, which hinders TGF‑β‑induced Smad nuclear translocation and transcriptional activity【1】.
• TB-500, as a thymosin beta‑4 fragment, sequesters G‑actin, lowering the pool of monomeric actin available for nuclear import. Reduced nuclear actin diminishes MRTF‑A/SRF and YAP/TAZ transcriptional complexes that sustain α‑SMA and collagen gene expression【2】.
• When both mechanisms are active, fibroblasts experience dual inhibition: (1) Smad‑mediated fibrotic transcription is dampened by BPC‑157‑induced PKG signaling, and (2) actin‑dependent mechanotransduction pathways that amplify Smad signaling are blunted by TB‑500‑driven G‑actin sequestration. This convergence should favor a fibroblast phenotype that expresses higher levels of matrix‑remodeling enzymes (MMP‑2/9) and lower levels of contractile markers, promoting functional tissue repair rather than scar formation.

Experimental Design

Model: Male Sprague‑Dawley rats subjected to left anterior descending coronary artery ligation to produce myocardial infarction. Groups (n=10 per group):

• Sham (surgery without ligation)
• MI + vehicle
• MI + BPC-157 (250 µg/kg subcutaneous, twice da

Hypothesis

Tissue-specific microRNA-mediated repression of ZMPSTE24 drives age‑dependent prelamin A accumulation in vascular smooth muscle, leading to CK2α sequestration and senescence.

Mechanistic basis

Recent work shows that prelamin A, not progerin, accumulates with declining ZMPSTE24 activity and directly binds CK2α, reducing its kinase activity and promoting senescence [2]. Aorta, heart and fat exhibit lamin A/C half‑lives an order of magnitude longer than liver or intestine [3], creating a window where reduced ZMPSTE24 translation can shift the lamin A processing balance. We hypothesize that vascular‑enriched microRNAs (e.g., miR-143/145 cluster) bind the 3′‑UTR of ZMPSTE24 mRNA, lowering its expression specifically in smooth muscle cells. This post‑transcriptional repression would produce a gradual rise in farnesylated prelamin A that sequesters CK2α at the nuclear envelope, dampening CK2‑dependent phosphorylation of substrates such as lamin B1 and histone H2B, thereby impairing DNA repair and promoting senescence.

Novel insight

Beyond the CK2α route, we propose that prelamin A‑induced changes in nuclear lamina mechanics alter the accessibility of chromatin domains tethered to LADs (lamina‑associated domains). Increased nuclear stiffness in prelamin A‑rich cells could hinder the movement of repair factors to sites of DNA damage, creating a CK2‑independent contribution to genomic instability.

Hypothesis

BPC-157 functions as an extracellular matrix‑bound allosteric modulator of the Growth Hormone Secretagogue Receptor (GHSR1a) that enhances growth hormone receptor (GHR) expression and JAK2 signaling in human tendon fibroblasts.

Mechanistic Rationale

1. Heparan sulfate proteoglycan (HSPG) tethering – BPC-157 contains a cluster of basic residues (Arg, Lys) that favor electrostatic binding to heparan sulfate chains on syndecans and glypicans, a motif shared with other fibroblast‑active peptides (e.g., FGF2) [1]. This interaction localizes BPC-157 to the pericellular matrix where GHSR resides.
2. Allosteric modulation of GHSR – Binding of BPC-157 to HSPG‑presented GHSR induces a conformational shift that increases the receptor’s basal activity and its sensitivity to endogenous ghrelin, analogous to how heparin potentiates FGF‑FGFR signaling. GHSR activation is known to cross‑talk with the JAK2‑STAT5 pathway via Src family kinases, thereby upregulating GHR transcription [2].
3. Rapid Egr-1 induction – The Src‑dependent phosphorylation of ERK1/2 downstream of GHSR can explain the observed 15‑minute rise in Egr-1 mRNA [3].
4. Nitric oxide modulation – GHSR signaling stimulates eNOS via the PI3K‑Akt pathway, increasing Nos3/Nos1 while suppressing Nos2/Nfkb, matching the NO profile reported for BPC-157 [4].
5. Species translation – Human tendon fibroblasts express both syndecan‑4 and GHSR1a at levels comparable to rodent Achilles tendon, providing a plausible conserved mechanism.

Testable Predictions

• If BPC-157’s activity depends on HSP

Background

Chronic low-grade inflammation in visceral adipose tissue (VAT) represents a critical pathophysiological mechanism underlying age-related metabolic dysfunction. Despite emerging evidence linking senescent macrophage accumulation to inflammatory cascades, targeted molecular interventions remain underdeveloped. Xu et al. demonstrated senescent cell burden correlates with inflammatory markers in metabolic syndrome (Nature Medicine, 2018), while Kirkland et al. validated senolytic approaches in preclinical models (Cell Metabolism, 2017).

Hypothesis

Selective pharmacological elimination of p16INK4a-positive senescent macrophages via dasatinib+quercetin will significantly attenuate pro-inflammatory SASP (senescence-associated secretory phenotype) signaling, reducing IL-6 and TNF-α mediated inflammatory responses in visceral adipose tissue.

Mechanistic Rationale

• Senescent macrophage accumulation drives chronic inflammatory signaling via SASP
• p16INK4a acts as a key molecular sentinel of cellular senescence
• Dasatinib targets tyrosine kinases promoting macrophage senescent cell clearance
• Quercetin provides complementary senolytic and anti-inflammatory mechanisms
• Interruption of NF-κB and JAK-STAT inflammatory pathways

We hypothesize that circulating soluble α‑Klotho, released from the kidney, directly protects cerebrovascular progenitor cells from phosphate‑driven mitochondrial dysfunction by scavenging intracellular ROS and restoring oxidative phosphorylation, a function that does not require its co‑receptor activity with FGF23.

Mechanistic Rationale

• α‑Klotho declines with age and correlates with progenitor cell mitochondrial impairment in renal tissue [1].
• Soluble α‑Klotho possesses intrinsic anti‑oxidative enzymes activities (e.g., β‑glucuronidase‑like) that can detoxify hydrogen peroxide and superoxide [3].
• Elevated serum phosphate, a hallmark of CKD and aging, induces ROS production in vascular progenitors, leading to senescence and impaired angiogenesis [2].
• In heart and liver, FGF23 signals via FGFRs independently of α‑Klotho, yet α‑Klotho amplifies FGFR binding twenty‑fold in kidney [3]; this suggests a tissue‑specific scaffolding role versus a systemic ligand role.
• Therefore, kidney‑derived soluble α‑Klotho may act as a circulating hormetin that mitigates phosphate toxicity in the brain vasculature without needing to modulate FGF23 signaling.

Testable Predictions

1. Administration of recombinant soluble α‑Klotho to aged mice with elevated serum phosphate will restore mitochondrial membrane potential and ATP production in isolated cerebra

If aging is a selected population-level trait, then pharmacological reversal of epigenetic aging via α‑ketoglutarate (AKG) will reduce individual fitness when cells or organisms compete for limited resources, unless the intervention is paired with a mechanism that mitigates the resulting resource demand.

Mechanistic Reasoning

AKG serves as a cofactor for TET enzymes, promoting DNA demethylation and thereby counteracting age‑associated hypermethylation that drives senescence [1, 2]. This epigenetic rejuvenation mirrors the natural reprogramming seen in early embryogenesis [6]. However, TET‑mediated demethylation also activates a set of genes that increase cellular biosynthetic activity, including those governing ribosome biogenesis and nucleotide synthesis. Elevated biosynthetic flux raises intracellular demand for nitrogen and carbon skeletons, which in turn augments glutaminolysis and the tricarboxylic acid (TCA) cycle.

In a resource‑limited environment, heightened biosynthetic activity creates a competitive cost: AKG‑treated cells consume more glutamine and glucose per unit time, leaving fewer nutrients for neighboring untreated cells. According to group‑selection models of programmed aging, such a cost would be selected against because it undermines the population‑level benefit of turnover [4, 5]. Therefore, the hypothesis predicts

Hypothesis: Age‑associated loss of duodenal GLP‑1‑secreting L‑cells results from a combined decline in visceral sensory innervation and Wnt‑dependent stem‑cell support, whereas colonic L‑cells persist due to residual nerve‑rich crypt niches. This nerve‑EEC communication sustains L‑cell longevity through activity‑dependent induction of the transcription factor c‑Fos, which maintains an epigenetic program preventing transdifferentiation. Aging reduces enteric neuron density, lowering c‑Fos activation in duodenal L‑cells and promoting their conversion to other enteroendocrine fates. Concurrently, age‑related enrichment of Akkermansia muciniphila inhibits Wnt signaling in intestinal stem cells, shrinking the progenitor pool that replenishes L‑cells. The duodenum, lacking the dense nerve‑enriched crypts seen in the colon, suffers a disproportionate loss of L‑cells, while colonic L‑cells retain survival signals from nearby visceral fibers. Elevated GIP from hyperplasia of K‑cells further antagonizes GLP‑1 action, exacerbating metabolic dysfunction.

Testable predictions: 1. In young mice, chemogenetic activation of duodenal visceral afferents will increase c‑Fos expression in L‑cells and extend their lifespan, as measured by lineage‑tracing reporters (e.g., Glucagon‑CreERT2;Rosa26‑tdTomato) over 14 days. 2. In aged mice, the same neuronal activation will fail to prolong L‑cell survival unless Wnt signaling is pharmacologically enhanced (e.g., with a PORCN agonist), indicating dependence on both nerves and Wnt. 3. Antibiotic‑mediated reduction of Akkermansia muciniphila in

Hypothesis

We hypothesize that intestinal autophagy generates a diffusible signal that travels to the brain through vagal afferents, where it alters the BCL-2/Beclin-1 complex in neurons to promote autophagy and thereby extend lifespan. This signal is a microbiota‑derived metabolite whose production depends on intestinal autophagy, and its action requires intact vagal signaling and neuronal AMPK activity.

Mechanistic Rationale

1. Intestinal autophagy controls metabolite release – Autophagy in gut epithelial cells shapes the composition of the luminal microbiome and the secretion of specific metabolites (e.g., indole‑3‑propionic acid, serotonin, or short‑chain fatty acids) that can cross the epithelial barrier [1]. When intestinal autophagy is impaired, the profile of these signaling molecules shifts toward pro‑inflammatory ligands.
2. Metabolite activates vagal afferents – Certain metabolites stimulate receptors on vagal sensory neurons (e.g., 5‑HT receptors for serotonin, FFAR2 for acetate) leading to action potential propagation to the nucleus tractus solitarius [2]. Vagal firing triggers downstream neuromodulatory pathways that converge on the hypothalamus and cortex.
3. Vagal signaling engages neuronal AMPK – Activation of vagal afferents increases norepinephrine release in the brainstem, which activates AMPK in downstream neurons via β‑adrenergic signaling. AMPK phosphorylates Beclin‑1 at Ser93/Ser96, reducing its affinity for BCL‑2 and liberating Beclin‑1 to initiate autophagosome formation [3].
4. **BCL-2/Beclin-1 modulation determines neuronal

Hypothesis

Age-related decline in NAD+ levels reduces SIRT1 activity, impairing the autophagy‑mediated rationing system that fuels β‑glucan‑induced trained immunity. Restoring NAD+ (e.g., with nicotinamide riboside) will rescue SIRT1‑dependent deacetylation of autophagy regulators, thereby sustaining metabolite supply from selective organelle turnover and preserving the epigenetic and functional hallmarks of trained immunity in aged monocytes.

Mechanistic Rationale

Trained immunity imposes a chronic "siege" on monocytes, demanding simultaneous glycolytic ATP production and biosynthetic precursors for chromatin remodeling [2][3]. Autophagy meets this demand by selectively degrading mitochondria and other metabolic compartments, liberating TCA‑cycle intermediates (succinate, fumarate) that reinforce HIF1α stabilization and epigenetic marks [1][4]. This process is not indiscriminate cleanup; it is a rationing decision governed by the energy‑sensing kinase mTOR and the deacetylase SIRT1. SIRT1 directly deacetylates key autophagy proteins (e.g., ATG5, LC3) and transcription factors (FOXO3) that promote autophagosome formation under nutrient stress [https://pubmed.ncbi.nlm.nih.gov/29563370/]. In aging monocytes, intracellular NAD+ falls, diminishing SIRT1 activity and tipping the balance toward mTOR‑driven anabolism without sufficient autophagic recycling. Consequently, the siege intensifies: cells expend internal reserves faster than they can be replenished, leading to premature exhaustion of the trained state.

Testable Predictions

1. Flux Prediction: Aged huma

Hypothesis

Transient senescence in gut epithelial cells sustains a homeostatic microbiome by releasing SASP factors that stimulate mucosal barrier integrity and microbial metabolite production; when senescent burden exceeds a tissue‑specific threshold, these same signals become pro‑inflammatory and disrupt microbiota‑gut‑brain signaling, worsening anxiety‑ and depression‑like phenotypes.

Mechanistic Rationale

1. Beneficial SASP in low‑burden senescence – Senescent epithelial cells secrete PDGF‑AA, TGF‑β, and indole‑3‑propionic acid (IPA) precursors that promote tight‑junction protein expression and stimulate commensal production of short‑chain fatty acids (SCFAs) [1][2]. These metabolites activate vagal afferents via free‑fatty‑acid receptors (FFAR2/3) and modulate HPA‑axis activity, dampening stress responses [5].
2. Threshold shift with accumulation – Persistent senescence amplifies SASP components such as IL‑6, IL‑1β, and MMP‑9, which increase intestinal permeability, facilitate translocation of lipopolysaccharide (LPS), and drive low‑grade systemic inflammation [3][4]. LPS engages TLR4 on enterochromaffin cells, altering serotonin synthesis and vagal signaling toward a pro‑anxiety state.
3. Microbiota feedback – Dysbiotic shifts induced by leaky gut reduce SCFA‑producing taxa, diminishing FFAR2/3 signaling and removing a brake on neuroimmune activation, creating a vicious loop that links gut senescence to mood pathology.

Testable Predictions

• Prediction 1: In aged mice (24‑mo), gut‑targeted senolytic treatment (e.g., navitoclax conjugated to

Hypothesis

We propose that the circadian clock directly times the assembly and disassembly of the primary cilium in stem cells, thereby gating Hedgehog (Hh) pathway activity to synchronize DNA damage response (DDR) with the metabolic cycle. In young tissue, BMAL1/CLOCK drive rhythmic expression of intraflagellar transport genes (e.g., IFT88, KIF3A) that produce oscillating cilium length; peak cilium presence during the active phase enhances SMO‑GLI signaling, which in turn promotes transcription of DDR factors such as BRCA1 and XPC. When the clock weakens with age, cilium oscillations flatten, Hh signaling becomes constitutively low or arrhythmic, and DDR falls out of phase with replication stress, leading to accumulated mutations and stem cell exhaustion.

Mechanistic rationale

• Clock‑cilium link: BMAL1 binds enhancers of IFT88 and tubulin genes, a relationship shown in liver where GLI knockdown disrupts PER2::LUC rhythms [6]. We extend this to suggest that BMAL1/CLOCK heterodimers drive daily pulses of ciliogenesis, creating a temporal window for Hh pathway activation.
• Hh‑DDR coupling: GLI transcription factors directly regulate promoters of nucleotide excision repair (NER) genes; prior work shows BMAL1/CLOCK regulate NER efficiency in a gene‑specific manner [1]. Thus, rhythmic GLI activity could impose a circadian schedule on NER capacity.
• Feedback from damage: DNA lesions trigger PER2 degradation and BMAL1 promoter activation [2]; loss of cilium‑mediated Hh signaling would blunt this feedback, further destabilizing the clock.
• **Stem cell n

Hypothesis: In the aged limbal epithelium, a subpopulation of senescent stromal and epithelial cells secretes an IL‑6‑rich SASP that activates STAT3 signaling in neighboring label‑retaining limbal epithelial stem cells (LESCs), thereby maintaining PAX6 transcription and preserving stem‑cell potency. Complete senolytic clearance of these cells removes this paracrine support, leading to diminished PAX6+ LESC numbers, reduced clonal regeneration, and compromised corneal transparency in native aging. This hypothesis is testable and falsifiable using aged mouse models and lineage‑tracing approaches.

Mechanistic

rationale: Recent work shows that transient SASP factors such as IL‑6 can promote stem‑cell self‑renewal through STAT3‑dependent transcription (see [2]). PAX6 expression is essential for LESC differentiation and corneal homeostasis ([4],[5]), yet its regulation by niche signals remains unexplored. We propose that senescent limbal cells, identified by p16^INK4a^ expression and SA‑β‑gal activity, produce IL‑6 and possibly exosomal miR‑205, which together activate STAT3 in adjacent LESCs. STAT3 phosphorylation drives direct binding to PAX6 enhancer regions, sustaining PAX6 mRNA and protein levels. In young tissue, this signal is transient; in aged tissue, senescent cells persist and become a chronic source of supportive IL‑6, creating a paradox where their removal harms regeneration.

Experimental plan: 1) Use p16-3MR mice to label senescent cells in limbal tissue of 18‑month‑old animals. 2) Treat cohorts with either the senolytic ABT‑263 (navitoclax) or a senomorp

Hypothesis

Intermittent dosing of dasatinib + quercetin (D+Q) combined with a low‑dose JAK1/2 inhibitor reduces senescent cell burden without inducing senescence‑like chromatin changes in non‑target tissues.

Rationale

Recent work shows that repeated D+Q courses can provoke senescence‑like chromatin alterations even in young cells, raising safety concerns for chronic use [6]. Conversely, JAK‑STAT signaling is a core driver of the SASP, and JAK inhibition attenuates SASP‑mediated inflammation without directly killing senescent cells [2][5]. By pairing intermittent senolysis with transient JAK blockade, we hypothesize that the senolytic pulse clears p16^high^ cells while the JAK inhibitor suppresses residual SASP from any surviving senescent cells, thereby preventing the paracrine induction of chromatin changes in neighboring cells.

Predictions

1. In diabetic kidney disease mouse models, intermittent D+Q (3 days on/4 days off) plus low‑dose ruxolitinib will lower renal p16^Ink4a^ and p21^Cip1^ mRNA levels to a greater extent than D+Q alone [2][3].
2. The combination will not increase H3K9me3 or DNMT3A expression in cortical tubular cells, markers associated with off‑target chromatin remodeling [6].
3. SASP cytokines (IL‑6, IL‑1α, MMP‑9) in serum and kidney homogenates will be significantly reduced relative to D+Q monotherapy, reflecting both senescent cell removal and SASP suppression [2][5].
4. Functional readouts (glomerular filtration rate, albuminuria) will improve comparably to D+Q alone, demonstrating that efficacy is not sacrificed.

Experimental Desig